Home › NCT04751409

Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities

Evaluating the Impact of Limited vs. Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Soft Tissue Sarcoma

Who can join

Ages 18 and older · All sexes

IInclusion Criteria:

* ≥18 years old
* Completion of sarcoma therapy (chemotherapy, radiation therapy and/or surgery) within 8-14 weeks of study enrollment
* Willingness to complete surveys x 2 years

Exclusion Criteria:

* Documented metastatic disease at the time of enrollment
* Non-English-speaking patients

Pregnant women will be included in this clinical trial.

About the study

This phase II trial studies how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage II-III soft tissue sarcoma of the trunk and extremities. In cancer survivors, the fear of cancer coming back (recurring) is common and may persist long after the end of treatment. It may also be exacerbated by return visits for imaging (surveillance). The purpose of this study is to determine how patients' anxiety and other cancer-related outcomes are affected by how often surveillance is done.

What is being tested

• Chest Radiography (procedure)
• Computed Tomography (procedure)
• Follow-Up (procedure)
• Follow-Up (procedure)
• Imaging Technique (procedure)
• Questionnaire Administration (other)

Sponsor: M.D. Anderson Cancer Center · Participants: 227 · Started: Dec 28, 2020

Contact the study team

• Christina L Roland, MD · Phone: 713-792-6940

Official record on ClinicalTrials.gov — NCT04751409

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.